Clinical Trial Update: Study of Carfilzomib in Combination w/Dexamethasone in Patients w/Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

This Phase 2 trial of carfilzomib plus dexamethasone in newly diagnosed multiple myeloma was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Emory University | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2015-11-04